Xeloda
Product Images NDC 54868-5260

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Xeloda (NDC 54868-5260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (150 mg Tablet Bottle Label)

Principal Display Panel (150 mg Tablet Bottle Label)
This is a description of a medicine bottle that contains a medication called SELODA with an NDC number of 543GR-4143-0. The medication has 60 tablets with a total distribution by Physicians Total Care and a weight of 158g. It also indicates the lot number as LOTY 690 E, WTE 010, and has a code 41430600000.*
FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

FDA Label Image

Chemical Structure (Xeloda 01)

FDA Label Image

Chemical Structure (Xeloda 02)

FDA Label Image

Figure 1 (Xeloda 03)

FDA Label Image

Figure 2 (Xeloda 04)

Figure 2 (Xeloda 04)
This appears to be a table with two columns showing data for two different cancer treatment options (5FU+Leucovorin and Capecitabine). The rows appear to correspond to different time points during the treatment (weeks or months perhaps) and show the percentage of participants in a treatment group who are still in the study at that point. The numbers at the bottom of each column may be sample sizes for each treatment group. Without additional context or clearer formatting, it is difficult to provide a more detailed description of what this data represents.*
FDA Label Image

Figure 3 (Xeloda 05)

Figure 3 (Xeloda 05)
This is a graph representing the Estimated Probability of the 5FU + Leucovorin treatment (Mayo Regimen) versus Xeloda 1250 (mo/sqm twice dally) intermittent treatment over a period of time in days. The text also shows the time interval labels of the X-axis.*
FDA Label Image

Figure 4 (Xeloda 06)

Figure 4 (Xeloda 06)
This appears to be a graph or chart showing the estimated probability of response to a treatment with Docetaxel 100 (mg/sqm/3 weeks) over time, with time measured in days. Unfortunately, without more context or labels on the chart, it is difficult to provide a more detailed description.*
FDA Label Image

Figure 5 (Xeloda 07)

Figure 5 (Xeloda 07)
This text appears to be a table with data on estimated probabilities for Docetaxel and XELODA treatment. It includes dosages and time intervals for both treatments, with corresponding estimated probabilities for various years. There is also a graph that shows time (in days) on the X-axis and an unknown unit on the Y-axis, with values ranging from 0 to 800. Additional context is necessary to understand the purpose of this data.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.